The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy

<table>(a) Transvaginal gray-scale ultrasonography revealing an irregular gestational cystic mass (FD) located within the isthmic area of the lower anterior wall of the uterus and protruding toward the uterine cavity. (b) Obvious and homogenous enhancement of the gestational sac after Gd-DTPA administration on axial T1-weighted imaging (arrow) without enhancement of the inner content. (c) Huge gestational sac (4.9 cm × 4.0 cm × 4.4 cm) showing high signal intensity on sagittal T2-weighted imaging (arrow) with low signal intensity inside.</table>

The Scientific World Journal

fig2

Figure 2

Figure 2: The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy 

Figure 2 | The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy 